AT-934

N/A

Report date: 2022/12/27 18:25:41
NME

Base Information

Drug NameAT-934
Drug Alias NameAT-934
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA-directed RNA polymerase L inhibitors
TargetsRNA-directed RNA polymerase L
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtea Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtea Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A